Suppliers Target Functional Foods with Postbiotic and Collagen Systems
Leading ingredient suppliers are commercialising integrated premixes and taste-masking technologies to move clinical actives from dietary supplements into mainstream beverages and snacks.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Las Vegas, United States — 22 October 2026
Kerry, dsm-firmenich, and Cargill are repositioning their primary active ingredient portfolios around hybrid functional beverage and food prototypes ahead of SupplySide Global in Las Vegas (28–30 October 2026). The shift directly addresses commercial migration away from conventional tablets and capsules towards ready-to-drink (RTD) beverages, protein powders, and savoury snacks.
Formulating therapeutic ingredients into functional foods introduces severe chemical and physical hurdles. Kerry is highlighting concepts incorporating its BC30 spore-forming probiotic alongside Plenibiotic postbiotics in ready-to-drink protein beverages and hydration formulations. Amy Smith, senior director of medical affairs at Kerry, noted that delivering evidence-aligned dosages inside acceptable serving sizes requires purpose-built taste masking and early processing condition screening to secure shelf-life stability.
Similarly, Cargill is pairing its EpiCor postbiotic with soluble corn fibre in a shrub spritz concept, alongside a sugar-free collagen and electrolyte formulation sweetened with EverSweet stevia and ClearFlo flavouring systems. By combining distinct positioning pillars—gut health, beauty-from-within, and hydration—suppliers are packaging multiple raw materials into single application briefs.
To support multi-active matrices, dsm-firmenich is showcasing its ModulaSense taste modulation platform across combinations containing Humiome Post LB, life’s Omega, Fruitflow, and resVida. Seletha Periman, senior director at dsm-firmenich, confirmed an accelerating commercial demand for pre-blended functional systems that shorten contract manufacturing turnaround times.
What this means for United States
US brand owners targeting domestic functional food categories face strict FDA labelling compliance under 21 CFR Part 101, requiring precise structure-function boundaries. Utilizing postbiotics over viable bacteria lowers operational overheads by eliminating temperature-controlled freight and cold storage, which routinely add 15% to 20% to interstate distribution costs. Brands pitching to national retail chains like Target and CVS must secure ambient shelf stability of at least 12 months to satisfy supplier vendor agreements. Adopting fully validated ingredient premixes from tier-one suppliers lowers contract minimum order quantities (MOQs) and mitigates costly line-trial scrap during scale-up.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.